Trials / Completed
CompletedNCT05795816
Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
The Effectiveness of Testofen on Energy, Fatigue, Mental Acuity, and Other Quality of Life Symptoms Post COVID-19 Infection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- RDC Clinical Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Testofen (a specialised extract of Trigonella foenum-graecum (Fenugreek) seed) compared to placebo on post COVID-19 symptoms in otherwise healthy participants 18 years and over.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testofen | Twice daily dose of 1 capsule (300mg per capsule Testofen) |
| DRUG | Microcrystalline cellulose | Twice daily dose of 1 capsule |
Timeline
- Start date
- 2023-10-25
- Primary completion
- 2025-01-30
- Completion
- 2025-01-31
- First posted
- 2023-04-03
- Last updated
- 2025-03-10
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05795816. Inclusion in this directory is not an endorsement.